Macro
Search catalysts, news stories, and pressures, or browse the trust-weighted news feed below.
Home
tech
energy
finance
healthcare
defense
industrial
consumer
communication
utilities
real estate
raw materials
← back
healthcare · sector mood
1998
year mood
+0.37
· +0.16 to +0.50 across 12 mo
Monthly mood
bearish −1
+1 bullish
month values ▾
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.40 | +0.40 | +0.16 | +0.50 | +0.40 | +0.40 | +0.40 | +0.30 | +0.30 | +0.40 | +0.40 | +0.40 |
March's Viagra launch became a cultural and commercial phenomenon for Pfizer, and my franchise thrived in the bull market; the August Russia/LTCM panic barely dented my defensive cash flows.
How this mood is scored ▾
Each day the model reads that day's news for the sector and asks, as someone who owns assets or
makes their living in it: how am I feeling this month, and why?
The month's mood is that running answer, tied to the specific events driving it (the story shown
above). It leans on trusted, higher-impact reporting, and on the prior month when a month is
quiet, so one loud headline can't swing it. The read updates daily through
the month; once a month ends, its mood is locked.
This year is read live from the news the pipeline actually collected (hover a bar for its story count).
· last computed Jul 11, 2026
Top healthcare stories of 1998
Mar
FDA approves Pfizer's Viagra, first oral treatment for impotence
sciencedaily.com →
The U.S. Food and Drug Administration (FDA) has approved Viagra (sildenafil citrate), developed by Pfizer, as the first oral medication for treating erectile dysfunction, a condition affecting millions of men. Clinical trials showed significant efficacy across diverse patient groups, with common side effects including headache and flushing, driving strong market anticipation for the drug's commercial launch.